Anxiety-like behavior in mice in two apparatuses during withdrawal from chronic ethanol vapor inhalation

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 7, 2004, Pages 1012-1019

  Kliethermes, C L ^a   Cronise, K ^a   Crabbe, J C ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL WITHDRAWAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; FEMALE; LONG TERM EXPOSURE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; VAPORIZATION; WITHDRAWAL SYNDROME;

ADMINISTRATION, INHALATION; ANIMALS; ANXIETY; DARKNESS; ETHANOL; FEMALE; LIGHTING; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 3242700578     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000131976.40428.8F     Document Type: Article

References (49)

1. Anton RF, Kranzler HR, McEvoy JP, Moak DH, Bianca R (1997) A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal. Psychopharmacology (Berl.) 131: 123-129.
2. Bourin M, Hascoet M (2003) The mouse light/dark box test. Eur J Pharmacol 463:55-65.
3. Cook MN, Crounse M, Flaherty L (2002) Anxiety in the elevated zero-maze is augmented in mice after repeated daily exposure. Behav Genet 32:113-118.
4. Crawley J, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167-170.
5. Dawson GR, Crawford SP, Collinson N, Iversen SD, Tricklebank MD (1995) Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology (Berl.) 118:316-323.
6. Driessen M, Meier S, Hill A, Wetterling T, Lange W, Junghanns K (2001) The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 36:249-255.
7. Espejo EF (1997a) Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behav Brain Res 87:233-238.
8. Espejo EF (1997b) Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behav Brain Res 86:105-112.
9. Fernandes C, File SE (1996) The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav 54:31-40.
10. File SE (1993) The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 58:199-202.
11. File SE (2001) Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 125:151-157.
12. File SE, Baldwin HA, Hitchcott PK (1989) Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat. Psychopharmacology (Berl.) 98:262-264.
13. File SE and Zangrossi Jr. H (1993) "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or development of a phobic states?, Psychopharmacology (Berl) 110:240-244.
14. Finn DA, Gallaher EJ, Crabbe JC (2000) Differential change in neuroactive steroid sensitivity during ethanol withdrawal. J Pharmacol Exp Ther 292:394-405.
15. Gallate JE, Morley KC, Ambermoon P, McGregor IS (2003) The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety. Psychopharmacology (Berl.) 166:51-60.
16. Gatch MB, Wallis CJ, Lal H (2000) Effects of ritanserin on ethanol withdrawal-induced anxiety in rats. Alcohol 21:11-17.
17. Gillman MA, Lichtigfeld FJ (2002) Randomized double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state. J Subst Abuse Treat 22:129-134.
18. Goldstein DB (1972) Relationship of alcohol dose to intensity of withdrawal signs in mice. J Pharmacol Exp Ther 180:203-215.
19. Goldstein DB (1973a) Convulsions elicited by handling: a sensitive method of measuring CNS excitation in mice treated with reserpine or convulsant drugs. Psychopharmacologia 32:27-32.
20. Goldstein DB (1973b) Inherited differences in intensity of alcohol withdrawal reactions in mice. Nature (Lond.) 245:154-156.
21. Goldstein DB, Pal N (1971a) Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science (Wash. DC) 172:288-290.
22. Goldstein DB, Pal N (1971b) Comparison of pyrazole and 4-brompyrazole as inhibitors of alcohol dehydrogenases: their potency, toxicity and duration of action in mice. J Pharmacol Exp Ther 178:199-203.
23. Grewal SS, Shepherd JK, Bill DJ, Fletcher A, Dourish CT (1997) Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats. Psychopharmacology (Berl.) 133:29-38.
24. Hascoet M, Bourin M, Dhonnchadha BA (2001) The mouse light-dark paradigm: a review. Prog Neuropsychopharmacol Biol Psychiatry 25: 141-166.
25. Henniger MS, Spanagel R, Wigger A, Landgraf R, Holter SM (2002) Alcohol self-administration in two rat lines selectively bred for extremes in anxiety-related behavior. Neuropsychopharmacology 26:729-736.
26. Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21-30.
27. Jung ME, Wallis CJ, Gatch MB, Lal H (2000) Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal. Alcohol 21:161-168.
28. Kliethermes CL, Finn DA, Crabbe JC (2003) Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice. Psychopharmacology (Berl).
29. Kosobud A, Crabbe JC (1986) Ethanol withdrawal in mice bred to be genetically prone or resistant to ethanol withdrawal seizures. J Pharmacol Exp Ther 238:170-177.
30. Kosten TR, O'Connor PG (2003) Management of drug and alcohol withdrawal. N Engl J Med 348:1786-1795.
31. Lal H, Prather PL, Rezazadeh SM (1991) Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone. Alcohol 8:467-471.
32. Lal H, Prather PL, Rezazadeh SM (1993) Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin Exp Res 17:411-417.
33. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.) 92:180-185.
34. Longo LP, Campbell T, Hubatch S (2002) Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. J Addict Dis 21:55-64.
35. Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC (2002) The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 17:349-355.
36. Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278:144-151.
37. Pokk P, Sepp E, Vassilev V, Valim M (2001) The effects of the nitric oxide synthase inhibitor 7-nitroindazole on the behaviour of mice after chronic ethanol administration. Alcohol Alcohol 36:193-198.
38. Quartermain D, Stone EA, Charbonneau G (1996) Acute stress disrupts risk assessment behavior in mice. Physiol Behav 59:937-940.
39. Rasmussen DD, Mitton DR, Green J, Puchalski S (2001) Chronic daily ethanol and withdrawal: 2. Behavioral changes during prolonged abstinence. Alcohol Clin Exp Res 25:999-1005.
40. Roberts AJ, Heyser CJ, Cole M, Griffin P, Koob GF (2000) Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22:581-594.
41. Roelofs SM (1985) Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol 2:501-505.
42. Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl.) 116:56-64.
43. Spanagel R, Montkowski A, Allingham K, Stohr T, Shoaib M, Holsboer F, Landgraf R (1995) Anxiety: a potential predictor of vulnerability to the initiation of ethanol self-administration in rats. Psychopharmacology (Berl.) 122:369-373.
44. Terdal ES, Crabbe JC (1994) Indexing withdrawal in mice: matching genotypes for exposure in studies using ethanol vapor inhalation. Alcohol Clin Exp Res 18:542-547.
45. Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF (2002) Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26:1494-1501.
46. Watson WP, Robinson E, Little HJ (1997) The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome. Neuropharmacology 36:1369-1375.
47. Weiss SM, Wadsworth G, Fletcher A, Dourish CT (1998) Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety. Neurosci Biobehav Rev 23:265-271.
48. Willinger U, Lenzinger E, Hornik K, Fischer G, Schonbeck G, Aschauer HN, Meszaros K (2002) Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol 37:609-612.
49. Wilson J, Watson WP, Little HJ (1998) CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze. Psychopharmacology (Berl.) 137: 120-131.